This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Arrys Therapeutics, Inc., Askat Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 15 
Years Active: 2021
Title: Atsushi Nagahisa: Innovator in Immuno-Oncology
Introduction
Atsushi Nagahisa is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of immuno-oncology, particularly through his innovative research and development of therapeutic agents.
Latest Patents
Nagahisa holds a patent for "EP4 inhibitors and use thereof." This invention provides the use of an agent that inhibits EP4 activity, along with an immuno-oncology agent or a composition thereof, for the treatment of cancer. His work in this area is crucial for advancing cancer therapies.
Career Highlights
Throughout his career, Atsushi Nagahisa has worked with notable companies, including Arrys Therapeutics, Inc. and Askat Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.
Collaborations
Nagahisa has collaborated with esteemed colleagues such as Mark Manfredi and Jeffrey Ecsedy. These partnerships have further enhanced his research and development efforts in the field of immuno-oncology.
Conclusion
Atsushi Nagahisa is a key figure in the development of innovative cancer treatments through his research on EP4 inhibitors. His contributions to the field of immuno-oncology are invaluable and continue to impact cancer therapy advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile